A59V (p.Ala59Val) variant of NPHS2 (Podocin)

A59V (p.Ala59Val) in NPHS2 (Podocin) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

A59V (p.Ala59Val) variant details